Register

Nitric Oxide Gas (VasoKINOX) 24 hour support through our 1800 NITRIC number

VasoKINOX® 450 ppm (nitric oxide for inhalation) is indicated in conjunction with ventilator support and other appropriate active substances to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery.

In summary for the 10 randomised controlled adult trials , iNO was effective in reducing PAP (expressed either directly as PAP or indirectly by PVR measurement) in adults with PHT in conjunction with cardiac surgery. In the studies that reported changes in PAP, the reduction of PAP was approximately from 15% to 40%¹

In summary for the 12 randomised controlled paediatric trials , iNO was effective in reducing PAP (expressed either directly as PAP or indirectly by PVR measurement) in children with PHT in conjunction with cardiac surgery. In all studies that reported changes in PAP, the reduction of PAP was approximately 10% to 30%²

Available in both a 5-litre and 11-litre cylinder, the new Air Liquide Healthcare labeling clearly identifies the medicine and its dosage form.

 
References: 1 and 2 VasoKINOX Product Information ARTG entry 235184

Sponsor: Air Liquide Healthcare Pty Ltd
VasoKINOX® AUST R 235184 manufactured by Air Liquide Sante France
SoKINOX™ manufactured by MAQUET CRITICAL CARE AB - Sweden
Medical Device Class llb C∈ 0123

Request Information

Resources